Jin Medical International Ltd. — Form 6-K Summary
Business Context and Reporting Period
Jin Medical International Ltd., a foreign private issuer based in Jiangsu Province, China, filed this Form 6-K for February 2024. The report was dated February 5, 2024, and concerns an approved subdivision of the Company’s ordinary shares.
Material Corporate Action
- Shareholders approved the subdivision by ordinary resolution at an extraordinary general meeting held January 30, 2024.
- Effective February 8, 2024, each issued and unissued ordinary share with a par value of US$0.001 will be subdivided into 20 ordinary shares with a par value of US$0.00005 each.
- Following the subdivision, authorized share capital will be US$50,000 divided into 1,000,000,000 shares with a par value of US$0.00005 per share.
- No fractional shares will be issued.
- Shareholders may contact the Company’s transfer agent, Transhare Corporation, for instructions on exchanging existing certificates for new certificates.
Financial Metrics and Outlook
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, guidance, or other operating and financial metrics. It does not include management commentary on business performance, risks, contingencies, or unusual financial items.
Most Important Facts to Verify
- Confirm that the 20-for-1 share subdivision became effective on February 8, 2024.
- Verify the resulting share count, par value, and authorized share capital in subsequent corporate filings and market records.
- Check whether trading symbols, quoted share prices, historical per-share data, and outstanding-share information were adjusted for the subdivision.
- Confirm procedures and deadlines with Transhare Corporation if holding certificated shares.